Key facts
- This page summarizes Dara Wright's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Dec 2023, 12:19.
Dara Wright - 16 Dec 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)
- Reporting relationship
- EVP, President, CDG
- Issuer ticker
- BIO
- Reported as of
- 16 Dec 2023
- Net transaction value
- -$53,265
- SEC form
- 4
- Accepted by SEC
- 19 Dec 2023, 12:19:02 UTC
- Prior SEC filing
- 12 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dara Wright
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Dara Wright filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 19 Dec 2023.
Change
- Previous filing in this sequence was filed on 12 Dec 2023.
- Current net transaction value: -$53,265.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIO BIOB
transaction
Bio-Rad A Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +502
- Change %
- +33%
- Price
- $0.000000
- Shares after
- 2,001
- Date
- 16 Dec 2023
- Ownership
- Direct
- Footnotes
- F1
BIO BIOB
transaction
Bio-Rad A Common Stock
Tax liability
- Transaction value
- $53,265
- Shares
- -174
- Change %
- -8.7%
- Price
- $306.12
- Shares after
- 1,827
- Date
- 16 Dec 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIO BIOB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -502
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 503
- Date
- 16 Dec 2023
- Ownership
- Direct
- Underlying class
- Bio-Rad A Common Stock
- Underlying amount
- 502
- Exercise price
- $0.000000
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Shares of Class A common stock acquired on the vesting of restricted stock units.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
Footnote F3
On December 16, 2019, the reporting person was granted 2,511 restricted stock units, vesting in 5 equal annual installments beginning on the first anniversary of the grant date.